Financials data is unavailable for this security.
View more
Income statement information is not available for Arecor Therapeutics PLC .
Gross margin | -- |
---|---|
Net profit margin | -278.81% |
Operating margin | -306.51% |
Return on assets | -50.32% |
---|---|
Return on equity | -67.81% |
Return on investment | -66.40% |
More ▼
Cash flow in GBPView more
In 2022, cash reserves at Arecor Therapeutics PLC fell by 13.55m. Cash Flow from Financing totalled 5.16m or 214.73% of revenues. In addition the company used 10.78m for operations while cash used for investing totalled 7.99m.
Cash flow per share | -0.2924 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.4314 |
---|---|
Tangible book value per share | 0.3237 |
More ▼
Balance sheet in GBPView more
Current ratio | 2.52 |
---|---|
Quick ratio | 2.28 |
Total debt/total equity | 0.0126 |
---|---|
Total debt/total capital | 0.0125 |
More ▼